Orbis Medication 3.x Safety Notice - DH Healthcare

ANSM Drug & Device Safety Alerts

Published March 31st, 2026

Detected March 31st, 2026

Summary

ANSM informed healthcare facilities of a safety action (n° R2607882) implemented by DH Healthcare GmbH regarding Orbis Medication 3.x, a computer-aided prescribing software. Users have received direct correspondence from the manufacturer. Healthcare providers using this software should review the attached safety communication.

View original document View source feed page

What changed

ANSM has recorded a safety action by DH Healthcare GmbH concerning Orbis Medication 3.x, a prescription assistance software (LAP). The safety action is registered under reference number R2607882. The manufacturer distributed a letter dated March 31, 2026, to affected users informing them of the safety measures taken.

Healthcare facilities and professionals using Orbis Medication 3.x should consult the attached manufacturer correspondence for specific safety action details. Direct inquiries should be directed to DH Healthcare GmbH. No specific compliance deadline or penalties are stated in this notice.

What to do next

Review the DH Healthcare GmbH safety communication regarding Orbis Medication 3.x
Direct questions about the safety action to DH Healthcare GmbH
Assess if Orbis Medication 3.x is in use at your facility and take appropriate follow-up actions

Source document (simplified)

A+ A-

Information n° R2607882 destinée aux services de soins, pharmacies d'usage intérieur L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société DH Healthcare Gmbh.
Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2607882.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société DH Healthcare Gmbh (31/03/2026)